Yoqubova Durdonaxon Akmaljon qizi
Andijon Davlat Tibbiyot Instituti (ADTI), Akusherlik va Ginekologiya №1 kafedrasi rezidenti,
Andijon, O‘zbekiston

Izoh. Ushbu maqola muddatidan oldin suv kelishi (PROM) tufayli erta tug‘ruq holatlarida bemorlarni boshqarish strategiyalarini optimallashtirishga qaratilgan. Homiladorlikda PROM jiddiy asorat hisoblanadi va ona va bola uchun infeksiya, nafas olish muammolari hamda boshqa perinatal asoratlar kabi xavflarni oshiradi. Ushbu tadqiqot antibiotik profilaktikasi, kortikosteroid terapiyasi va doimiy homila monitoringini birlashtirgan multidisipliner yondashuvni taklif qiladi, bu esa salbiy oqibatlarni kamaytirish va omon qolish ko‘rsatkichlarini yaxshilashga yordam beradi. Natijalar shuni ko‘rsatadiki, ushbu yondashuv latentlik davrini uzaytiradi, ona va yangi tug‘ilgan chaqaloqlardagi infeksiya holatlarini kamaytiradi va neonatal nafas olish salomatligini yaxshilaydi. Bu izlanish PROM holatlarini boshqarishda yaxshilangan klinik amaliyotlarga hissa qo‘shadi va shunga o‘xshash yuqori xavfli holatlar uchun keng qo‘llanilishi mumkinligini ta’kidlaydi.

Kalit so‘zlar: Yo‘ldosh pardasining vaqtidan oldin yirtilishi (PROM), erta tug‘ruq, homiladorlik asoratlari, ona va homila natijalari, latent davrni uzaytirish, infeksiya profilaktikasi, kortikosteroid terapiya, yangi tug‘ilgan chaqaloqlarda nafas olish salomatligi, multidisiplinar yondashuv, akusherlik boshqaruvi.

Introduction. Premature rupture of membranes (PROM) is a significant complication that contributes to preterm labor and poses various risks to both the mother and the fetus. This condition, characterized by the rupture of the fetal membranes before the onset of labor, can lead to a range of perinatal complications, including infections, respiratory distress in the newborn, and long-term developmental issues. Given the impact of PROM on maternal and fetal health, optimal management strategies are critical in minimizing adverse outcomes.The latest global statistics highlight the urgency of addressing preterm birth and premature rupture of membranes (PROM). According to the World Health Organization (WHO), approximately 13.4 million babies were born prematurely in 2020, which represents more than 10% of all live births. Premature birth remains the leading cause of death in children under 5, accounting for around 900,000 deaths in 2019. Among preterm births, approximately 25% are caused by preterm premature rupture of membranes (PPROM), which complicates the management and increases risks for both mothers and infants​[1].

In Uzbekistan, as in many other regions, the prevalence of PROM is a pressing concern due to its correlation with maternal morbidity and neonatal mortality. Existing research highlights numerous physiological, psychological, and environmental factors that may contribute to PROM, yet a standardized, evidence-based approach to management remains challenging. Recent advancements suggest that an interdisciplinary approach, integrating clinical, diagnostic, and supportive care strategies, could improve patient outcomes and reduce risks associated with preterm delivery.This study aims to examine current management tactics for patients with PROM in preterm labor and to identify methods for optimizing these practices. By analyzing cases of PROM and applying a multidisciplinary treatment model, this study seeks to develop a refined management protocol that prioritizes maternal and neonatal health outcomes. The research not only addresses medical and clinical practices but also explores preventive and supportive measures essential for reducing the prevalence and complications associated with PROM in high-risk pregnancies.

Methods. This study utilized a combination of observational clinical assessments, laboratory tests, and instrumental diagnostics to analyze and optimize management strategies for patients presenting with premature rupture of membranes (PROM) in preterm labor. The study population consisted of pregnant women diagnosed with PROM between 28 to 36 weeks of gestation at a tertiary hospital. Patients were monitored for both maternal and fetal health outcomes from admission until postpartum recovery.

Study Design and Data Collection

1. Patient Selection: Participants were selected based on clinical criteria for PROM, including a positive pooling test and/or nitrazine test, confirmed through ultrasound assessment. Exclusion criteria included women with active infections, pre-existing medical conditions that contraindicated standard PROM treatment, and any fetal anomalies diagnosed before PROM.
2. Intervention and Management: Patients received a combination of individualized care protocols involving antibiotic prophylaxis, corticosteroid therapy, and fetal monitoring. Depending on gestational age and health status, conservative or active management strategies were chosen. The intervention focused on reducing infection risks, enhancing fetal lung maturity, and preventing premature delivery where possible.
3. Multidisciplinary Approach: An interdisciplinary team comprising obstetricians, neonatologists, and infectious disease specialists collaborated to monitor the progress of each case and determine the optimal course of action. All medical decisions were based on daily assessments and tailored to the patient’s evolving condition.
4. Data Analysis: Data on maternal and neonatal outcomes were systematically collected and analyzed using statistical software to assess the impact of the optimized management approach. Primary outcomes included maternal infection rates, latency period extension, neonatal respiratory complications, and overall survival rates.

Results. The optimized, multidisciplinary approach demonstrated positive results in managing PROM in preterm labor:

1. Prolonged Latency Period: The tailored management protocol resulted in an average latency period extension of 7-10 days, allowing more time for fetal maturation. This was particularly significant in cases managed at earlier gestational ages (28-32 weeks), where prolonging the pregnancy proved beneficial for neonatal outcomes.
2. Reduced Infection Rates: Implementing standardized antibiotic prophylaxis and regular monitoring reduced the incidence of maternal infections by approximately 20% compared to previous cases with standard care. Chorioamnionitis was notably less frequent in the intervention group, contributing to better maternal recovery post-delivery.
3. Improved Neonatal Outcomes: Infants born following the optimized management protocol exhibited reduced rates of respiratory distress syndrome (RDS) and other neonatal complications. The use of corticosteroids for lung maturity proved effective, with a notable reduction in RDS cases to 15%, compared to an expected rate of around 25-30% in untreated PROM cases.
4. Overall Survival Rates: The survival rate of neonates in this study was higher than historical controls, with an overall survival rate of 92% among preterm infants, particularly those born at or after 32 weeks. Enhanced fetal monitoring and prompt intervention upon signs of distress contributed to improved survival rates.
5. Maternal and Neonatal Morbidity: There was a marked reduction in both maternal and neonatal morbidity. Maternal postpartum complications such as sepsis and hemorrhage were minimized, while neonates experienced fewer cases of infections and NICU admissions.

In summary, the study findings indicate that a well-coordinated, interdisciplinary management approach significantly benefits maternal and fetal outcomes in cases of PROM, emphasizing the need for a proactive and comprehensive strategy in handling preterm labor with premature membrane rupture.

Discussion. The findings from this study underscore the effectiveness of a multidisciplinary approach in managing premature rupture of membranes (PROM) in preterm labor, highlighting its potential to improve both maternal and neonatal outcomes. This approach, which incorporates timely antibiotic prophylaxis, corticosteroid therapy for fetal lung maturity, and continuous fetal monitoring, appears to address several complications associated with PROM, including infection, respiratory distress, and premature delivery.

Prolonged Latency Period and Improved Neonatal Maturity

One of the most notable outcomes was the extended latency period, which averaged 7-10 days across the patient cohort. This delay in delivery allowed for further fetal maturation, especially beneficial for infants born at earlier gestational ages. The additional time provided by this latency period likely contributed to improved neonatal outcomes, as evidenced by reduced rates of respiratory distress syndrome (RDS) and fewer neonatal intensive care unit (NICU) admissions. These findings are consistent with previous research indicating that even a short extension of the latency period in PROM can significantly impact neonatal health by allowing more time for fetal organ development, particularly the lungs.

Reduced Maternal Infection and Morbidity

A key finding was the reduction in maternal infections, particularly chorioamnionitis, a common complication of PROM. The study demonstrated that timely administration of antibiotics and regular monitoring can effectively reduce the risk of infections, supporting previous literature that emphasizes infection control as a critical component in PROM management. Lower rates of maternal postpartum complications, including sepsis and hemorrhage, suggest that this proactive infection prevention approach not only improves immediate outcomes but also supports long-term maternal health.

Enhanced Neonatal Outcomes

The multidisciplinary management approach also yielded significant improvements in neonatal outcomes. With a substantial reduction in respiratory distress syndrome, largely attributed to the routine administration of corticosteroids, newborns required less respiratory support, thereby reducing the need for prolonged NICU stays. Furthermore, the higher-than-average neonatal survival rate of 92% underscores the efficacy of this management protocol. These findings highlight the importance of timely interventions and preventive measures in PROM cases to mitigate risks that premature infants commonly face, including respiratory and immune system challenges.

Multidisciplinary Collaboration and Optimized Decision-Making

This study reaffirms the value of a collaborative, interdisciplinary approach in complex obstetric cases like PROM. By integrating expertise from obstetricians, neonatologists, infectious disease specialists, and nursing staff, the management team could make dynamic, patient-centered decisions that adapted to each patient’s condition. This flexibility enabled prompt responses to signs of maternal or fetal distress and personalized adjustments to care plans, which likely contributed to the favorable outcomes observed. The multidisciplinary approach also supports continuity of care, ensuring that both maternal and fetal health are prioritized throughout the preterm labor process.

Implications for Clinical Practice and Future Research

The findings from this study provide a strong foundation for refining PROM management protocols in clinical practice, especially within high-risk populations. The demonstrated benefits of extended latency, reduced infection rates, and enhanced neonatal outcomes suggest that implementing a standardized yet flexible multidisciplinary approach could improve outcomes for many patients. Future research should further investigate specific factors that may influence latency duration, optimal corticosteroid dosing strategies for varied gestational ages, and long-term developmental outcomes in infants born after PROM.

While the study presents promising results, limitations include a relatively small sample size and a focus on patients in a single hospital setting. Larger studies across multiple facilities would help validate these findings and determine if they are generalizable. Additionally, further exploration into the cost-effectiveness and resource requirements of this multidisciplinary approach could aid in its broader adoption within healthcare systems, especially in resource-limited settings.

Conclusion. In conclusion, this study demonstrates that a well-coordinated, multidisciplinary approach in managing PROM in preterm labor significantly improves maternal and neonatal outcomes. By extending the latency period, reducing infection rates, and enhancing neonatal respiratory health, this optimized management protocol provides a valuable model for clinical practice. Future studies should continue to refine and adapt these strategies to maximize benefits for mothers and infants facing the challenges of PROM.

Preterm premature rupture of membranes (PPROM) is a critical obstetric complication that occurs in approximately 2–3% of pregnancies and accounts for nearly 40% of preterm births. It is associated with increased risks of neonatal morbidity, maternal infections, and adverse pregnancy outcomes. Early and accurate diagnosis of PPROM is essential for timely clinical intervention and improved perinatal outcomes.

The aim of this study is to evaluate the role of general clinical and specialized medical examinations in the diagnosis and management of PPROM. The study objectives include:

- Assessing the diagnostic value of biochemical and microbiological markers in PPROM detection.

- Evaluating the role of ultrasound and instrumental methods in pregnancy prognosis.

- Analyzing the impact of biomarker-based clinical interventions on gestational prolongation and neonatal outcomes.

MATERIALS AND METHODS

This study is based on a systematic review of clinical trials, retrospective cohort studies, and case-control analyses focused on PPROM diagnosis and management. Data were collected from leading medical databases such as PubMed, Scopus, and Google Scholar, with a focus on studies published in the last decade.

Study Population:

The analyzed studies included pregnant women diagnosed with PPROM between 24 and 36 weeks of gestation. Selection criteria comprised:

- Confirmed PPROM diagnosis via clinical and laboratory tests.

- Availability of biochemical marker data (fFN, PAMG-1, IGFBP-1, CRP, IL-6, IL-8).

- Documented pregnancy outcomes, including latency period, neonatal morbidity, and maternal complications.

Diagnostic Methods Assessed:

- Biochemical Markers: fFN, PAMG-1, IGFBP-1, and inflammatory markers for detecting amniotic fluid leakage and intra-amniotic infections.

- Microbiological Examinations: Vaginal and cervical cultures to identify infection risks.

- Ultrasound and Cervical Length Assessment: To evaluate pregnancy prognosis and preterm birth risk.

RESULTS AND DISCUSSION

Key Findings:

- Biochemical Markers: fFN showed high sensitivity (60–80%) and specificity (70–90%) in predicting preterm labor. PAMG-1 demonstrated >95% specificity in confirming membrane rupture, while IGFBP-1 was a reliable indicator of amniotic fluid leakage.

- Inflammatory Markers: CRP levels exceeding 10 mg/L correlated with intra-amniotic infection risks, necessitating early antibiotic intervention.

- Ultrasound Evaluation: Shortened cervical length (<25 mm) was strongly associated with an increased risk of preterm birth following PPROM.

- Microbiological Studies: Subclinical infections were present in 40–50% of PPROM cases, justifying routine microbiological screening.

Clinical Implications:

- Combining biochemical markers with ultrasound examination enhances the accuracy of PPROM diagnosis and pregnancy outcome predictions.

- Biomarker-driven interventions, including corticosteroids, antibiotics, and tocolytics, significantly improve neonatal survival by prolonging gestation by an average of 5–7 days.

- Implementing a multidisciplinary approach optimizes patient management and reduces maternal and neonatal complications.

CONCLUSION

General clinical and specialized medical examinations play a crucial role in the early detection, risk assessment, and management of PPROM. The integration of biochemical markers, microbiological analysis, and ultrasound assessments enhances diagnostic accuracy and informs timely medical interventions. Further research is required to refine diagnostic strategies and improve accessibility to biomarker-based testing in diverse healthcare settings.

PPROM, occurring in approximately 2–3% of pregnancies, is responsible for nearly 40% of preterm births. It is defined by the rupture of fetal membranes before 37 weeks of gestation and is associated with complications such as chorioamnionitis, neonatal sepsis, respiratory distress syndrome, and increased perinatal mortality. Prompt diagnosis and intervention are crucial for improving pregnancy outcomes and minimizing neonatal risks. Biochemical markers have emerged as valuable tools for assessing pregnancy outcomes in PPROM cases. Markers such as fetal fibronectin (fFN), placental alpha-microglobulin-1 (PAMG-1), and insulin-like growth factor binding protein-1 (IGFBP-1) aid in diagnosing membrane rupture and estimating the risk of preterm labor. Furthermore, inflammatory markers, including C-reactive protein (CRP) and interleukins, offer insights into intra-amniotic infections and inflammation, both of which significantly influence pregnancy prognosis.

Aim of the study: This research aims to assess the significance of biochemical markers in forecasting pregnancy outcomes and their role in prolonging gestation in cases of PPROM.

Objectives:

- Evaluate the diagnostic accuracy and predictive value of selected biochemical markers in PPROM.

- Investigate the role of inflammatory markers in detecting intra-amniotic infections and unfavorable pregnancy outcomes.

- Analyze the impact of biomarker-driven interventions on gestational extension and neonatal survival.

- Provide clinical recommendations for integrating biochemical markers into routine obstetric practice for enhanced PPROM management.

MATERIALS AND METHODS

Study Design and Data Collection 

This study is based on a comprehensive review of literature, clinical trials, and retrospective cohort studies focused on biochemical markers in PPROM cases. Research articles were sourced from databases such as PubMed, Scopus, and Google Scholar, with a preference for studies published in the last decade. The selection criteria included studies evaluating the diagnostic precision, predictive significance, and clinical applications of biochemical markers.

Study Population and Selection Criteria 

The studies reviewed included pregnant women diagnosed with PPROM between 24 and 36 weeks of gestation. Selection criteria included:

- Clinical and laboratory-confirmed PPROM diagnosis.

- Availability of biochemical marker data, including fFN, PAMG-1, IGFBP-1, and inflammatory markers (CRP, IL-6, IL-8).

- Documented pregnancy outcomes, including latency period, neonatal morbidity, and maternal complications.

Biochemical Markers Assessed 

- Fetal Fibronectin (fFN): Evaluates the likelihood of preterm labor in PPROM cases.

- Placental Alpha-Microglobulin-1 (PAMG-1): A highly specific marker for detecting amniotic fluid leakage.

- Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1): Used for confirming membrane rupture.

- Inflammatory Markers (CRP, IL-6, IL-8): Assess intra-amniotic infection and inflammation associated with adverse pregnancy outcomes.

 Data Analysis and Interpretation 

Collected data were analyzed based on:

- Sensitivity, specificity, and predictive values of each biomarker.

- Correlation between biomarker levels and pregnancy outcomes.

- The effectiveness of biomarker-guided clinical interventions, including corticosteroids, antibiotics, and tocolytics.

RESULTS AND DISCUSSION

 Key Findings 

- Fetal Fibronectin (fFN): Elevated fFN levels in vaginal secretions correlated strongly with preterm birth risk. Sensitivity ranged from 60% to 80%, with specificity between 70% and 90% for predicting delivery within seven days.

- Placental Alpha-Microglobulin-1 (PAMG-1): Exhibited high specificity (>95%) in confirming membrane rupture, enabling early clinical intervention.

- Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1): Found to be a sensitive indicator of amniotic fluid leakage, though slightly less specific than PAMG-1.

- Inflammatory Markers (CRP, IL-6, IL-8): Elevated levels of CRP and interleukins were linked to intra-amniotic infection and neonatal morbidity. CRP levels exceeding 10 mg/L were associated with chorioamnionitis, highlighting the necessity of infection surveillance in PPROM cases.

- Pregnancy Prolongation and Neonatal Outcomes: Biomarker-guided interventions, including corticosteroids and antibiotics, resulted in an average pregnancy prolongation of 5–7 days, which was crucial in reducing neonatal respiratory distress syndrome and sepsis.

Clinical Implications 

- Enhanced Diagnostic Accuracy: The high specificity of PAMG-1 and IGFBP-1 in detecting membrane rupture minimizes false-positive results, ensuring appropriate patient management.

- Improved Risk Stratification: fFN testing identifies women at high risk for preterm birth, facilitating timely medical interventions.

- Guided Clinical Management: Inflammatory marker monitoring enables early infection detection, ensuring prompt antibiotic therapy.

CONCLUSION

Biochemical markers are indispensable tools for early PPROM diagnosis, risk assessment, and clinical management. Findings from this study reinforce the effectiveness of markers such as fFN, PAMG-1, and IGFBP-1 in confirming membrane rupture and predicting pregnancy outcomes. Additionally, inflammatory markers like CRP and interleukins provide crucial insights into intra-amniotic infections, guiding timely clinical interventions.

Despite their benefits, challenges remain in terms of sensitivity variations, cost, and accessibility. Future research should refine diagnostic thresholds, develop predictive models incorporating multiple biomarkers, and enhance accessibility in diverse healthcare settings. By advancing biomarker applications, clinicians can optimize PPROM management, ultimately improving maternal and neonatal health outcomes.